Mixed Chimerism and Clinical Outcome of Hematopoietic Stem Cell Transplantation in Glanzmann Thrombasthenia: Experience on 2 Siblings and Literature Review
Case report on two siblings who underwent allo-HSCT for glanzmann thrombasthenia, suggesting potential for cure and importance of monitoring integrin levels.
Key Points
Successful outcomes from allo-HSCT in two pediatric cases of glanzmann thrombasthenia highlight the potential for cure.
Monitoring platelet integrin levels, particularly αIIb and β3, is crucial for identifying graft rejection risks in patients.
The analysis includes comprehensive data from 2008 to 2022, providing additional context for the efficacy of allo-HSCT in treating GT.
Findings emphasize the importance of platelet aggregation assessment in managing severe glanzmann thrombasthenia and preventing bleeding.